• <em>FCGR3A</em> F158V alleles frequency differs in multiple myeloma patients from healthy population
• A bioinspired supramolecular nanoprodrug for precision therapy of B-cell non-Hodgkin's lymphoma
• A consistency comparison between next-generation sequencing and the FISH method for gene rearrangement detection in B-cell lymphomas
• A Mystery in a Case: Unraveling the Complexity of Bing-Neel Syndrome
• A Rare Case of Atrial Septal Mass Secondary to Lymphoma: Case Report and Review of Literature
• A Rare Case of Refractory Nodal Marginal Zone Lymphoma in a Child, Successfully Cured by Allogeneic Stem Cell Transplant: A Case Report
• Acute Abdominal Pain as the Initial Presentation of an Acquired C1 Inhibitor Deficiency
• Applications of cell therapy in the treatment of virus-associated cancers
• Assessment of Ki-67 Proliferative Index in Cytological Samples of Nodal B-Cell Lymphomas
• Association of race/ethnicity and insurance with survival in patients with diffuse large B-cell lymphoma in a large real-world cohort
• Bayesian sparse regression for exposure-response analyses of efficacy and safety endpoints to justify the clinical dose of valemetostat for adult T-cell leukemia/lymphoma
• BCL6 confers resistance to HDAC inhibitors in DLBCL
• Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I/II trial
• Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial
• Breast Carcinoma Coexistent with Ipsilateral Axillary Non-Hodgkin Lymphoma: Cytological Diagnosis Aided with Cellblock Immunohistochemistry
• Cancer risk among people living with Human Immuodeficiency Virus (HIV) in Rwanda from 2007 to 2018
• Cancer Statistics from the Shaukat Khanum Memorial Trust's Hospital-based Cancer Registry, Pakistan, 1994-2022: An Observational Study
• CD19 CAR T cells for B cell malignancies: a systematic review and meta-analysis focused on clinical impacts of CAR structural domains, manufacturing conditions, cellular product, doses, patient's age, and tumor types
• Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data
• Characteristics and Management of Patients With Cancer and Atrial Fibrillation: The BLITZ-AF Cancer Registry
• Clinical analysis of 10 cases with subcutaneous panniculitis-like T-cell lymphoma and tissue AURKA expression
• Clinical and Biomarker Characteristic of Lymphoma Patients in Hasan Sadikin Lymphoma Registry
• Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group
• Clinical features and prognostic analysis of colorectal extranodal NK/T cell lymphoma
• Clinical Outcome of Patients Receiving Rituximab in Combination with Bendamustine in Indolent B-cell Lymphomas: A Single-center Institutional Study
• Clinical Presentation, Management, and Outcome in Neurolymphomatosis: A Systematic Review
• Clinicopathological diagnosis of Lennert lymphoma: a case report and review of the literature
• Coexistence of non-Hodgkin lymphoma and multisystem hydatid cysts; successful albendazole therapy for muscular hydatid cysts: A case report
• Combination therapy of targeting CD20 antibody and immune checkpoint inhibitor may be a breakthrough in the treatment of B-cell lymphoma
• Comparisons of treatment outcomes of epcoritamab versus chemoimmunotherapy, polatuzumab-based regimens, tafasitamab-based regimens, or chimeric antigen receptor T-cell therapy, in third-line or later relapsed/refractory large B-cell lymphoma
• Comprehensive insight into exploring the potential of microbial enzymes in cancer therapy: Progress, challenges, and opportunities: A review
• Concurrent identification of follicular lymphoma and papillary thyroid carcinoma
• Correlation Between the Hepatitis C Virus NS3 Protein and CD30 Expression in Diffuse Large B-cell Lymphoma
• Costs of care during chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell lymphomas
• Cutaneous T cell Lymphoma in Skin of Color: A Review
• Diffuse large B-cell lymphoma with multiple bone involvement as the initial symptom of frontal mass: a case report
• DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphoma
• Effect of body mass index on the prognosis of children and adolescents with high-grade mature B-cell non-Hodgkin lymphoma
• Epidermodysplasia Verruciformis and Vδ2 γδ T-cell Expansion in STK4 Deficiency
• Evaluating pirtobrutinib for the treatment of relapsed or refractory mantle cell lymphoma
• Evaluation of the incidence, predictors, risk assessment scores and outcomes of thromboembolism in a cohort of Egyptian NHL patients - Real World Experience
• Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
• Factors influencing timely diagnosis in neurolymphomatosis
• Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy
• Fluid Overload-Associated Large B-Cell Lymphoma with Light Chain Restriction Type Plasma Cell Infiltration: A Case Report
• From trials to statistical insights: Bortezomib's story in childhood T-cell lymphoid malignancies
• Gastrointestinal Follicular Lymphoma of the Cecum Treated via Endoscopic Full-Thickness Resection
• H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma
• Hematological malignancy-associated pyoderma gangrenosum: evaluating the magnitude of the association
• Hematological Second Primary Malignancy in Pediatric Retinoblastoma: A Case Report and Systematic Review
• Hemophagocytic syndrome secondary to invasive NK cell leukemia and T-cell lymphoma treated with the modified MINE protocol: report of three cases and literature review
• HHV-8+ diffuse large B-cell lymphoma with EBV coinfection occurring posttransplant
• Histone deacetylase inhibitor and PD-1 blockade synergistically inhibit B-cell lymphoma progression in mice model by promoting T-cell infiltration and apoptosis
• Identification of genetic subtypes in follicular lymphoma
• Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms
• Impact of Primary Disease Site of Involvement by Early-Stage Follicular Lymphoma on Patient Outcomes
• Indolent T-cell lymphoma of the gastrointestinal tract with synchronous diffuse large B-cell lymphoma: report of a case
• Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma
• Intestinal Perforation in a Case of Peripheral T Cell Lymphoma after Initiation of Chemotherapy
• KMT2D mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-beta1 axis
• Knowledge, skills, and confidence gaps impacting treatment decision making in relapsed/refractory chronic lymphocytic leukemia and mantle cell lymphoma: a quantitative survey study in France, Germany, and the United States
• LMP1 enhances aerobic glycolysis in natural killer/T cell lymphoma
• Maxillary Diffuse Large B-Cell Lymphoma Enshrouded as Osteomyelitis: A Case Report
• MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesis
• MegaAppendix: a rare case of mantle cell lymphoma in an appendix presented as volvulus
• Melanoma as Subsequent Primary Malignancy in Hematologic Cancer Survivors-A Literature Review
• Mogamulizumab‐assoziierter Rash – Fallserie und aktuelle Literatur
• Multiantigen T-Cell Hybridizers: A Two-Component T-Cell-Activating Therapy
• Multiple primary diffuse large B-cell lymphoma masquerading as meningioma
• Natural killer cell-associated prognosis model characterizes immune landscape and treatment efficacy of diffuse large B cell lymphoma
• Navigating Diagnostic and Therapeutic Challenges in Primary Cutaneous Gamma/Delta T-Cell Lymphoma: A Case Study of Fatal Outcomes Within Two Months
• New and developing first line pharmacotherapies for treating non-Hodgkin lymphoma
• Non-Hodgkin lymphoma incidence, mortality, and survival trends in Brunei Darussalam from 2011 to 2020
• Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma
• Obinutuzumab-Induced Inflammatory Bowel Disease-Like Pancolitis: A First Case Report
• Phase IB Study of Oral Selinexor in Combination with Rituximab and Platinum Chemotherapy in Patients with Relapsed/Refractory B-Cell Lymphoma-Final Analysis
• Policy and perspective on outpatient programs for autologous hematopoietic cell transplantation and immune-effector cell therapy administration
• Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor Types
• Primary Sjögren's syndrome without ocular manifestation: a case report
• Progress in deciphering the role of p53 in diffuse large B-cell lymphoma: mechanisms and therapeutic targets
• Rare case of mantle cell lymphoma of the lacrimal sac
• Ready, AIM, stop: ibrutinib plus venetoclax in MCL
• Recombinant hirudin and PAR-1 regulate macrophage polarisation status in diffuse large B-cell lymphoma
• Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial
• Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma
• Secondary Breast Burkitt Lymphoma Involving the Stomach, Ovary, Pancreas, and Bones: A Case Report
• Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy
• Spectrum of imaging findings of primary bone lymphoma in pediatric patients
• Synchronous Invasive Ductal Carcinoma of Breast and Diffuse Large B-cell Lymphoma: A Case Report
• T-Cell Neoplasms after B-Cell Neoplasms - The Pre-CAR T-Cell Era
• Targeted multiplex validation of CSF proteomic biomarkers: implications for differentiation of PCNSL from tumor-free controls and other brain tumors
• Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study
• TCP1 expression alters the ferroptosis sensitivity of diffuse large B-cell lymphoma subtypes by stabilising ACSL4 and influences patient prognosis
• The Great Impostor: A challenging case of small-cell melanoma with isolated adrenal metastasis
• The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification
• Time-dependent change of T cell receptor clonality: From large plaque parapsoriasis to early mycosis fungoides
• Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation
• Trousseau's Syndrome: A Paraneoplastic Complication
• Unusual Presentation of Non-Hodgkin Lymphoma of Two Cases: Case Report
• Vitreoretinal large B- cell lymphoma (VR- LBCL): Clinical and pathological features and treatment outcomes